Turning cancer research into trading success with 2,000 percent gain, Richard Moglen reveals

Turning cancer research into trading success with 2,000 percent gain, Richard Moglen reveals
Harvard researcher earns 2,000 percent return

Richard Moglen announced the premiere of his interview with Tito Adhikary, a Harvard cancer researcher who became an options trader. Adhikary achieved over 2,000 percent return trading growth stocks with options during the 2025 USIC.

A preview of the interview was shared, highlighting Adhikary's transition from research to finance.

Adhikary’s remarkable trading performance comes amid broader market dynamics that Richard Moglen has addressed, including developments such as RMV reaching zero and the emergence of potential support zones. This interview also provides further context for Moglen’s ongoing analysis of strong equity trends, following his examination of revenue acceleration within the Lite trend.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.